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Abstract:  We  present  a  multiplexed,  Fourier-domain  low  coherence 
interferometry (mLCI) instrument for in vivo measurement of intravaginal 
microbicide  gel  coating  thickness  distribution  over  the  surface  of  the 
vaginal epithelium. The mLCI instrument uses multiple delivery fibers to 
acquire depth resolved reflection profiles across large scanned tissue areas. 
Here  mLCI  has  been  adapted  into  an  endoscopic  system  with  a  custom 
imaging  module  for  simultaneous,  co-registered  measurements  with 
fluorimetric scans of the  same surface. The resolution,  optical signal-to-
noise, and cross-talk of the mLCI instrument are characterized to evaluate 
performance. Validation measurements of gel thickness are made using a 
calibration socket. Initial results from a clinical study are presented to show 
the  in  vivo  capability  of  the  dual-modality  system  for  assessing  the 
distribution  of  microbicide  gel  vehicles  in  the  lower  human  female 
reproductive tract. 
© 2011 Optical Society of America 
OCIS  codes:  (120.3180)  Interferometry;  (120.3890)  Medical  optics  instrumentation; 
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1. Introduction 
The  HIV/AIDS  epidemic  continues  to  overwhelm  current  preventative  measures.  This  is 
especially true in sub-Saharan Africa where women experience two-thirds of new infections, 
and  young  women are 3-5 times  more likely  to be infected than  males of the same age. 
Clearly, there is a need for a discreet, female-controlled method of protection from the HIV 
virus that women can use proactively and independently [1]. 
Microbicide gels are topical products that are being developed in order to protect against 
sexually transmitted infections, including HIV/AIDS. Recently, the CAPRISA 004 trial of a 
tenofivir microbicide gel showed a 39% reduction of HIV transmission vs. control population 
[2]. A quality microbicide gel is one that incorporates a potent active ingredient into a robust 
delivery system, e.g. a gel, and achieves targeted drug delivery to target tissues and fluids. In 
order  to  evaluate  the  effectiveness  of  microbicide  gels,  accurate  measurement  of  their 
intravaginal gel coating thickness distributions is necessary. 
Previously,  two  optical  imaging  methodologies  have  been  applied  for  measuring 
microbicide  gel  distribution.  A  fluorescence-based  instrument  was  developed  and  used  to 
measure  coating  thickness  of  fluorescein  labeled  gel  vehicles  [3–5].  There  is  concern, 
however,  that  the  label  may  separate  from  the  gel  over  time,  thereby  confounding  the 
interpretation of the scans of local fluorescence intensity. Consequently, we have developed a 
multiplexed, Fourier-domain low coherence interferometry system for label free measurement 
of gel distribution [6,7]. This system was successfully validated in phantom studies [3,4,6,7]. 
We now present an endoscopic platform that integrates these two techniques—mLCI and 
fluorimetry—into  a  single  instrument  to  enable  simultaneous  in  vivo  imaging  of  gel 
distribution using both modalities. The combination allows validation of the mLCI system for 
measuring gel thickness distributions without the need of exogenous contrast agents [7]. To 
develop the platform, our original mLCI instrument was modified and a compact imaging 
module  was  created  for  integration  with  the  fluorescence  endoscope.  In  this  study,  we 
evaluate the clinical mLCI instrument’s performance with test measurements from a custom 
calibration socket, as well as demonstrate preliminary in vivo measurements of vaginal gel 
coating thickness distribution in women. 
2. Instrumentation and probe design 
The clinical mLCI device is based on six parallel fiber optic Michelson interferometers, as 
shown  below  in  Fig.  1.  Light  from  a  superluminescent  diode  (SLD,  Superlum  Diodes, 
Moscow, Russia, λo = 837.5-nm  λ = 54.2) is split into eight channels (six are used) by a 1x8 
fiber coupler (AC Photonics, Santa Clara, CA). 
Six 50:50 fiber optic couplers (AC Photonics) are used to create the reference and sample 
arms for each interferometer. In the reference arm of each channel, light is collimated by a 
fiber  optic  collimator  (AC  Photonics)  and  reflected  off  of  a  reference  mirror.  Each  arm 
includes a fiber optic shutter to enable selective gating of each reference arm. In the sample 
arm,  the  six  fibers  are  routed  together  through  a  protective  polyetheretherketone  (PEEK) 
sheath into the fluorescence system’s endoscopic probe. This allows the probe to be mounted 
in  its  existing  frame,  with  just  the  mLCI  sample  arm  fibers  interfaced  with  the  existing 
fluorimetric instrument setup [3]. The optical fibers are then bonded to a silicon v-groove  
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Fig. 1. System schematic of the clinical, multiplexed LCI instrument. Light from a SLD is split 
into 8 channels, 6 of which are used, by a 1x8 fiber optic splitter. Six 50:50 fiber optic couplers 
are then used to create reference and sample arms for each parallel interferometer. Fiber optic 
collimators are used to collimate and collect the reference light reflected off of the mirror array 
for each channel of the instrument. The sample arm fibers are routed through a protective 
sheathing,  into  the  endoscopic  probe,  and  secured  into  a  custom  imaging  module.  The 
reference  and  sample  fields  are  recombined  by  the  six  50:50  couplers  and  detected 
simultaneously by a six-channel spectrometer. 
 
Fig. 2. mLCI imaging module. (a) Top view of optical components: L1-3mm cut ball lens; L2-
6mm cut ball lens. (b) Side view of module components. (c) Schematic of the mLCI imaging 
module mounted on the endoscope. (d) 3-D layout of the imaging module. 
chip (OZ Optics, Ottawa, Ontario, CA) which acts to protect the fibers as well as enable 
precise  alignment.  Figure  2  shows  the  mLCI  imaging  module  that  is  adapted  to  permit 
measurement within the distal end of the endoscopic fluorescence probe. 
In the imaging module, lens, L1, collimates the light from each of the fibers. A 3-mm 
right angle prism creates a 90-degree bend in the light path necessary for the side-firing probe 
design. Lens, L2, focuses the light through a 3.175 mm thick polycarbonate tube and onto the 
sample. The signal beam reflected by the sample is recombined with the reference field and 
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allows simultaneous detection of all 6 interference signals. The system is operates at a speed 
of 48 scans/s in this application, but the spectrometer is capable of reaching speeds up to 1620 
scans/s [7]. Path length between each sample and reference arm is matched by adjusting the 
fiber optic collimators in each reference arm relative to one another in a custom mount. Once 
each individual channel is matched, the entire group can be moved with the translation stage 
shown in Fig. 1 for gross alignment. 
The imaging module shown in Fig. 2(d) is a custom mount, machined from aluminum and 
secured to the end of the existing endoscopic probe using machine screws. This configuration 
offsets the  mLCI field of view by 180° azimuthally and 20 mm axially from that of the 
fluorescence system as shown in Fig. 2(c), but this is compensated for during data processing. 
The imaging module also acts to secure the v-groove chip, and allows 3-axis positioning of 
the v-groove chip. The 3-mm ball lens (L1) was epoxied to the face of the 3 mm right angle 
prism, and this assembly is secured into a well in the imaging module. The 6 mm ball lens 
(L2)  was  secured  as  in  Fig.  2(d)  to  the  imaging  module.  Four  screws  allow  for  precise 
alignment  of  this  optic.  The  entire  rigid  endoscope  is  contained  in  a  27  mm  diameter, 
polycarbonate tube (150 mm long)  with a hemispherical  cap, as shown in Fig. 3(c). The 
internal endoscope is then able to freely rotate and translate relative to the polycarbonate tube 
so that measurements can be made at sites that span the length and circumference of the tube. 
The  measurement  positions  vary  along  the  vagina  over  360°  of  azimuthal  angle  and 
approximately 100 mm axially. The design in Fig. 2(c) allows increased lateral sampling and 
broad  tissue  coverage  without  the  use  of  electromechanical  galvanometer  scanners  in  the 
probe, typical of many optical coherence tomography systems. The finished system is housed 
on  a  12x12  in.  aluminum  breadboard  mounted  to  a  stainless  steel  utility  cart  for  simple 
maneuverability, as shown in Fig. 3. 
 
Fig. 3. Photographs of the multiplexed LCI instrument: (a) enclosed system on the cart (b) 
system components visible with the cover removed; SLD-superluminescent diode; OI-optical 
isolator; FS-fiber optic switches; RC-reference arm collimators; RM-reference arm mirrors, 
TS-translation stage; FC-50/50 fiber optic couplers. (c) Close-up of probe tip with reference to 
a U.S. dime. 
The clinical cart contains the mLCI instrument, multichannel spectrometer, SLD driver, 
and positional encoder interface, used to couple the mLCI instrument with the fluorimetry 
system. The positional encoder interface consists of a USB NI-DAQ that is used to capture 
the  longitudinal  and  angular  positioning  coordinates  of  the  probe  from  the  fluorimetric 
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are then used to co-register the mLCI and fluorimetric data during post-processing. 
3. System characteristics 
3.1 Signal processing 
The signal, I, captured by the detector of each channel of the spectrometer is given by 
 
2 2 2Re[ cos(2 )] s R s R I I I I I zk φ = + + +   +    (1) 
where IS and IR are the sample and reference fields,  z is the optical path length difference 
between  the  arms  of  the  interferometer,  k  is  the  corresponding  wavenumber  of  the  light 
source, and φ is a phase term. As optical path length difference increases, the frequency of 
spectral oscillations increases as well. Optical path length can be linearly related to physical 
thickness, t, with the simple equation  z = nt, where n is the index of refraction of the sample, 
which is generally a known or measurable quantity for gel vehicles. 
Prior to instrument application, it is necessary to perform a background measurement to 
enable  subtraction  of  noninterferometric  and  common  path  interference  signals  from  the 
captured spectra, I. Before the endoscope is placed into the polycarbonate tube, the signal IR is 
captured. The endoscope assembly is then placed into the polycarbonate tube and the signal ID 
is obtained. At each measurement point, computer controlled mechanical fiber optic shutters 
are used to capture IS immediately prior to data acquisition, to minimize fluctuations in the 
subtracted signal. The background subtracted spectra is then given by 
  ( ) RAW R S D I I I I I = − + −    (2) 
The interference spectrum is then converted from wavelength, λ, to wavenumber, k, by the 
transformation, k = 2π/λ, and resampled using a spline interpolation to restore linear spacing. 
The  wavenumber  interference  spectra  is  then  digitally  corrected  for  chromatic  dispersion 
effects and Fourier transformed to reveal the spatial cross correlation between the reference 
field and sample reflectors. 
3.2 Instrument performance 
Optical signal-to-noise (OSNR) was determined for each channel of the system by using a 
single reflector in place of the sample. OSNR can then be calculated as 






= +    (3) 
where ES is the amplitude of the processed interference spectrum from the mirror surface, EN 
is the standard deviation of the shot noise, and ND is the attenuation of a neutral density 
optical filter which is used to prevent detector saturation due to the relatively strong signal 
from the mirror reflector. OSNR values range from 87 to 113 dB, and are summarized in 
Table 1. These results show marked improvement over the first generation multiplexed LCI 
instrument [7]. 
Axial resolution was determined for each channel of the mLCI system. Again, a mirror 
was  used  as  the  sample,  and  the  full  width  at  half  maximum  (FWHM)  of  the  resultant 
reflection profile was determined. The FWHM results, defining the axial resolution for each 
channel, are shown in Table 1. While these results are consistent with the first generation 








   (4) 
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[7,8]. The use of fiber optics and differences in optical components between the sample and 
reference arms of the  mLCI system lead to chromatic dispersion in the system, and thus 
decreased resolution and variations in OSNR from channel to channel. Off axis focusing of 
the  light  from  the  multiple  channels  in  the  imaging  module  causes  the  relatively  small 
differences in axial resolution between the channels as seen in Table 1. As in the previous 
generation system described by Drake et al., chromatic dispersion in the mLCI system is 
digitally corrected, improving resolution and approaching the theoretical limit [7]. 
Table 1. Measured optical signal-to-noise (OSNR) and axial resolution 
Channel  1  2  3  4  5  6 
OSNR (dB)  90.83  87.55  102.50  92.58  110.90  113.56 
Axial Resolution (µm)  9.6  9.2  8.3  6.8  7.0  8.7 
Cross-talk between the mLCI channels was also examined, in order to characterize the 
performance of the clinical instrument. A single channel was connected to the SLD light 
source, and optical power was measured at the detector of the adjacent channels. Cross-talk is 
then given by 







=    (5) 
where PAS is the cross-talk from an adjacent fiber, PA, to the signal fiber, PS [9]. Cross-talk is 
negligible in the clinical mLCI system as all values were found to be less than −53dB. 
4. Device performance using a calibration socket 
A custom machined calibration socket was used to verify the accuracy and linearity of the 
mLCI instrument. The test socket is used for calibration of the fluorimetric system and it was 
used  as  an  accurate  model  to  test  the  linearity  and  accuracy  of  the  mLCI  instrument, 
independently  verifying  both  modalities  against  the  same  standard  [3,4].  The  test  socket 
consisted of an aluminum half cylinder with five grooves of varying depth, from 150  m to 
500  m, as shown in Fig. 4(a). These depths are representative of those previously measured  
 
 
Fig. 4. Calibration socket validation: (a) photograph of the calibration socket with a placebo 
gel (dyed pink), (b) plot of mLCI measurements versus those taken with digital calipers, (c) b-
scan of the three wells of the socket where the red lines illustrate socket depth (from digital 
caliper measurement) and the blue lines illustrates the point where a single a-scan of the 310 
 m well in (d) was captured. 
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placed into the socket and measured with the clinical mLCI instrument. This gel was the 
commercial  vaginal  moisturizer  Replens  (LDS  Consumer  Products,  Cedar  Rapids,  IA). 
Fluorimetric  imaging  studies  of  the  vaginal  coating  of  this  gel  have  previously  been 
performed [3,4]. Measurements were taken in each of the five grooves, the measurements 
from all six channels were averaged, and these were compared to those from digital calipers. 
Figure  4(b)  shows  excellent  agreement  between  the  two  methods,  with  a  correlation 
coefficient of 0.9947, and a slope of 1.0082. The y-axis error bars are determined from the 
axial resolution values given in Table 1, and the x-axis error is given by the uncertainty of the 
digital  calipers,  or  ±5   m.  These  results  are  comparable  to  those  of  previous  generation 
systems, such as Braun et al. and Drake et al. [2,7]. 
By translating the calibration socket and capturing an A-scan, or axial depth scan, at every 
3.5-mm of lateral position using a single, central channel (channel 3), the tomographic image 
in Fig. 4(c) was created. Three of the five wells are clearly seen in the image, and the depths 
again correlate with those of the digital calipers. Figure 4(d) shows a single A-scan from the 
image (blue line in Fig. 4(c)), and the peak at approximately 310  m reveals the expected 
depth of the well. 
5. Human in vivo feasibility measurement 
With  the  incorporation  of  mLCI  imaging  optics  into  the  fluorimetric  endoscopic  probe, 
simultaneous  in  vivo  measurements  of  gel  coating  are  now  possible.  Device  performance 
shown in this pilot study results from in vivo measurements of the test gel, Replens (n = 1.34), 
in  a  single  human  subject.  This  gel  is  considered  a  useful  biophysical  model  of  current 
microbicidal gel products [3,4,12]. 
5.1 Clinical data acquisition 
Initially, the polycarbonate tube is lubricated with a thin coating of non-labeled Replens for 
insertion. The physician then inserts the lubricated tube assembly into the subject’s vagina 
and adjusts an opaque flange to eliminate ambient light. The tube is then zero-positioned, 
with 0° oriented vertically, and the endoscope advanced entirely towards the fornix defined as 
0-mm. The tube is then locked in place, so that it remains stationary during the course of the 
measurements. The physician then manually advances the endoscope inside the polycarbonate 
tube distally towards the introitus, capturing mLCI measurements at 1-mm increments and 
fluorescence  measurements  at  5-mm  increments.  This  sampling  method  is  performed  to 
achieve equal coverage of the two modalities in the axial direction, since the fluorimetric 
system  has a larger field of view than the  mLCI instrument [3,7]. Once an axial scan is 
completed, the physician then rotates the endoscope 45° and continues the scan towards the 
fornix. Once advanced entirely to 0°, the endoscope is rotated another 45° and this sequence 
continues until an entire 360° mapping of the vagina is completed, and the probe is removed 
Once this background scan is finished, 3.5 mL of fluorescein-labeled Replens is inserted 
into the subject’s vagina for the test scan. There is then a waiting period, during which the 
participant  executes  a  defined  protocol  of  activity  in  private.  In  the  study  here,  after  gel 
insertion, the participant remained seated for 1 minute, stood for 1 minute, and then was 
seated for 1 minute; she then assumed a supine position for 7 minutes. This protocol is typical 
of those used to capture a woman’s posture after application of a microbicide gel and prior to 
sexual activity. That is,  this  protocol captures that period during  which  microbicide drug 
delivery by the gel can lead to a prophylactic concentration of drug—which is governed by 
the vaginal surface coating measured here—prior to exposure to HIV. The physician then re-
inserts the entire probe assembly into the subject’s vagina, to the same axial depth as the 
background scan. The scan procedure is repeated, until the entire 360° mapping of the surface 
of the vagina is completed. In total, approximately 750 regions are sampled with mLCI for 
the background and final scans, each region comprising 4 A-scans yielding a total of 3000 A-
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1 minute; minimum = 36 minutes). 
5.2 Clinical data processing 
The mLCI measurements must be properly reconciled with the fluorimetric data, since mLCI 
data are sampled 5-times more frequently and offset from the fluorimetric data due to the 
endoscope  design.  First,  the  mLCI  data  set  is  rotated  by  180°  and  shifted  −20  mm  to 
compensate for the field-of-view offset. Then, for each fluorimetric measurement point, five 
consecutive axial mLCI scans are averaged to compensate for the larger field of view of the 
fluorimetric system. The background scan and test scan are both processed in this manner. 
Finally, a point-to-point subtraction of the background scan from the test scan is performed in 
order to remove any effects from the non-labeled gel used for probe insertion. 
5.3 Clinical data results 
Figure 5 shows the coating thickness distributions obtained from our human in vivo data, 
presented as a topological plot, with gel thickness represented by the colorbar. Zero degrees is 
aligned with vertical orientation, and 0 mm is closest to the fornix (deepest portions of the 
vagina). The 20 mm axial offset between the modalities is clearly seen in Fig. 5, as the mLCI 
data extends further towards the fornix. 
 
Fig. 5. Human in vivo microbicide gel coating measurements: (a) Fluorimetric system and (b) 
mLCI instrument. The colorbar shows coating depth in  m. 
The fraction of scanned vaginal surface with detectable coating was calculated for each 
modality: the mLCI instrument was found to have a value of 0.4500 while the fluorimetric 
system had a value of 0.4453, for an absolute difference of 0.0047, or 1.06%. The fraction of 
scanned vaginal surface with coating thickness > 50  m was also calculated since this is a 
putative threshold of minimum coating thickness needed for a microbicide gel at any position 
over the vaginal epithelium. The clinical mLCI instrument produced a value of 0.3265 and the 
fluorimetric method had a value of 0.2891, with an absolute difference of 0.0374, or 12.9%. 
We believe that this difference is not biologically significant, based on our studies of HIV and 
drug transport through distributed gel coatings [10,11]. 
Figure 6 shows the contour lines of the fluorimetric coating data superimposed onto the 
topological  plot  from  the  mLCI  thickness  distribution  data.  Qualitatively,  the  coating 
distributions appear to correlate spatially, as the areas with coating overlap and are distributed 
within approximately 50 mm of the fornix. Again, the 20 mm axial offset between the data 
sets is seen as the fluorimetric contour lines begin at 20 mm axial distance. It should be noted 
that at thicker distributions of gel coating, greater than approximately 600  m, the mLCI 
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mLCI  system  lacks  penetration  depths  at  such  thick  gel  layers.  However,  since  we  are 
investigating coatings that exceed a minimum thickness, this upper threshold does not alter 
our analysis. 
 
Fig. 6. Contour lines of the fluorimetric coating data overlaid on a topological plot of the mLCI 
coating data. 
6. Summary 
In this paper, we have demonstrated a multiplexed, Fourier-domain mLCI system that has 
been  adapted  to  a  fluorimetric  endoscope  system  for  simultaneous,  multimodal  optical 
imaging of microbicide gel coating distribution over the vaginal epithelial surface in women 
in vivo. We showed that the  mLCI system obtained comparable results to the previously 
validated fluorimetric system, but without the need for extraneous contrast agents. The mLCI 
system  also  achieved  broad  area  scanning  over  large  tissue  area  without  the  need  of 
electromechanical  scanners  typical  of  many  optical  coherence  tomography  systems.  The 
resolution,  optical  signal-to-noise,  and  cross-talk  of  the  multiplexed  system  were 
characterized, and an in vitro validation experiment was performed on a custom calibration 
socket. In vivo measurements from a clinical study of a placebo microbicide gel have been 
presented to demonstrate the ability of the clinical mLCI system to obtain vaginal gel coating 
distributions. Studies have shown that a coating layer with a thickness in excess of 50  m 
may be sufficient enough to neutralize HIV before it can contact epithelium tissue and result 
in an infection, and the mLCI instrument demonstrated the ability to measure distributions at 
this scale [11]. These pilot results are comparable to the previously validated fluorimetric 
system.  They  demonstrate  that  this  new  system  offers  significant  promise  for  measuring 
vaginal gel coating thickness distributions in vivo, in clinical studies of anti-HIV microbicide 
gels  and  also  other  gel  therapeutic  and  prophylactic  products.  Based  on  the  validation 
presented here, we expect that future studies will be performed solely with the mLCI device, 
eliminating the need for exogenous contrast agents for imaging and allowing for extended 
time studies. Gel distributions from large time intervals (6–12 hours) between gel insertion 
and imaging cannot currently be studied with the fluorimetry system because of diffusion of 
the fluorophore from the gel to the tissue. The mLCI device offers promise to perform such 
studies, allowing us to gain a better understanding of in vivo gel distributions as they would 
appear with actual use of a microbicide gel product. 
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